Digestive Health Market By Type, By Form, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031

List of Tables

The global digestive health market was valued at $38,789.13 million in 2021, and is projected to reach $90,205.67 million by 2031, registering a CAGR of 8.8% from 2022 to 2031.

Digestive health is one of the main concerns that everyone talks about every day. The overall health of a person can be greatly impacted by an unhealthy gut and thus, to avoid the same, the body needs nutrients to ensure normal digestive function and to maximize the benefits from their diet, which includes a wide range of products from probiotics to digestive enzymes. These promote healthy body function and assist in management of pathogenic microbes from the mouth to stomach. In addition, probiotics supplements assist in digestion process and enhance nutrient absorption when used in proper amount.

According to the National Center for Biotechnology Information (NCBI), gastrointestinal diseases affect an estimated 60 to 70 million people annually in America, with colorectal cancer as the 2nd leading cancer type diagnosed among American men and women. Thus, there is a growing prevalence of digestive diseases around the globe, which further propels the need for digestive health products.

Furthermore, growth of the digestive health market is anticipated to be facilitated by introduction of numerous advancements in products by the pharmaceutical and nutraceutical companies, increase in demand for solutions to treat chronic digestive diseases, and availability of wide range of products and supplements that are easily accessible and cost-effective.

Moreover, with growth in trend of "Gut Health-Key of Weight Management," prebiotics manufacturers are scrambling to keep up with the rising demand for prebiotics globally. Researchers discovered that the bacteria in the gut, which aid in digestion and absorption of nutrients in intestines, can affect capacity to lose weight, thus leading to rise in demand for prebiotics among weight conscious population and propelling the market growth.

Rse in digestive issues among individuals, owing to lack of sports and fitness activities, growing focus of the population on healthy nutrition, and rise in investments by consumers in probiotics for digestive health and rising preference for functional foods, along with new product launches, propel the market growth. Whereas, increase in R&D initiatives by key market players provide lucrative opportunities for growth of the market.

Although, there are various factors that propel the market growth, there are few restraints that affect the market including stringent government regulations and high development cost associated with the manufacturing process. For instance, the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (the Bioterrorism Act) requires dietary supplement companies to register with FDA and provide FDA with sufficient information to contact companies in an emergency.

The digestive health market is segmented on the basis of product, form, distribution channel, and region. By product, it is divided into prebiotics, probiotics, and digestive enzymes. On the basis of type, it is segmented into capsules, tablets, and others. By distribution channel, it is segmented into drug stores & retail pharmacies, online providers, and others (supermarkets/hypermarkets). The drug stores & retail pharmacies segment is further divided into prescription and OTC (over-the-counter). Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include Amway Corporation, Bayer AG, BASF SE, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., Nestle SA, NOW Health Group Inc., Pfizer Inc., Sanofi, and the Bountiful Company (Nature's Bounty).

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digestive health market analysis from 2021 to 2031 to identify the prevailing digestive health market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the digestive health market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global digestive health market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

Prebiotics
Probiotics
Digestive Enzymes

By Form

Capsule
Tablet
Others

By Distribution Channel

Drug Stores and Retail Pharmacies
- Type
- Prescription
- OTC
Online Providers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
Key Market Players
- Bayer AG
- GalaxoSmithKline PLC
- Pfizer Inc.
- Sanofi
- Nestle SA
- Herbalife Nutrition Ltd.
- BASF SE
- NOW Health Group Inc.
- Amway Corporation
- The Bountiful Company (Nature's Bounty)

Product Code: A31458

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Patent Landscape

CHAPTER 4: DIGESTIVE HEALTH MARKET, BY TYPE

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Prebiotics
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Probiotics
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
4.4 Digestive Enzymes
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country

CHAPTER 5: DIGESTIVE HEALTH MARKET, BY FORM

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Capsule
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Tablet
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Others
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country

CHAPTER 6: DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Drug Stores and Retail Pharmacies
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.2.4 Drug Stores and Retail Pharmacies Digestive Health Market by Type
  - 6.2.4.1 Prescription Market size and forecast, by region
  - 6.2.4.2 OTC Market size and forecast, by region
6.3 Online Providers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country

CHAPTER 7: DIGESTIVE HEALTH MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Form
- 7.2.4 North America Market size and forecast, by Distribution Channel
  - 7.2.4.1 North America Drug Stores and Retail Pharmacies Digestive Health Market by Type
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Type
  - 7.2.5.1.2 Market size and forecast, by Form
  - 7.2.5.1.3 Market size and forecast, by Distribution Channel
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Type
  - 7.2.5.2.2 Market size and forecast, by Form
  - 7.2.5.2.3 Market size and forecast, by Distribution Channel
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Type
  - 7.2.5.3.2 Market size and forecast, by Form
  - 7.2.5.3.3 Market size and forecast, by Distribution Channel
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Form
- 7.3.4 Europe Market size and forecast, by Distribution Channel
  - 7.3.4.1 Europe Drug Stores and Retail Pharmacies Digestive Health Market by Type
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Type
  - 7.3.5.1.2 Market size and forecast, by Form
  - 7.3.5.1.3 Market size and forecast, by Distribution Channel
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Type
  - 7.3.5.2.2 Market size and forecast, by Form
  - 7.3.5.2.3 Market size and forecast, by Distribution Channel
  - 7.3.5.3 UK
  - 7.3.5.3.1 Market size and forecast, by Type
  - 7.3.5.3.2 Market size and forecast, by Form
  - 7.3.5.3.3 Market size and forecast, by Distribution Channel
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Type
  - 7.3.5.4.2 Market size and forecast, by Form
  - 7.3.5.4.3 Market size and forecast, by Distribution Channel
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Type
  - 7.3.5.5.2 Market size and forecast, by Form
  - 7.3.5.5.3 Market size and forecast, by Distribution Channel
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Type
  - 7.3.5.6.2 Market size and forecast, by Form
  - 7.3.5.6.3 Market size and forecast, by Distribution Channel
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Form
- 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
  - 7.4.4.1 Asia-Pacific Drug Stores and Retail Pharmacies Digestive Health Market by Type
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Market size and forecast, by Type
  - 7.4.5.1.2 Market size and forecast, by Form
  - 7.4.5.1.3 Market size and forecast, by Distribution Channel
  - 7.4.5.2 China
  - 7.4.5.2.1 Market size and forecast, by Type
  - 7.4.5.2.2 Market size and forecast, by Form
  - 7.4.5.2.3 Market size and forecast, by Distribution Channel
  - 7.4.5.3 Australia
  - 7.4.5.3.1 Market size and forecast, by Type
  - 7.4.5.3.2 Market size and forecast, by Form
  - 7.4.5.3.3 Market size and forecast, by Distribution Channel
  - 7.4.5.4 India
  - 7.4.5.4.1 Market size and forecast, by Type
  - 7.4.5.4.2 Market size and forecast, by Form
  - 7.4.5.4.3 Market size and forecast, by Distribution Channel
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Market size and forecast, by Type
  - 7.4.5.5.2 Market size and forecast, by Form
  - 7.4.5.5.3 Market size and forecast, by Distribution Channel
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Market size and forecast, by Type
  - 7.4.5.6.2 Market size and forecast, by Form
  - 7.4.5.6.3 Market size and forecast, by Distribution Channel
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Form
- 7.5.4 LAMEA Market size and forecast, by Distribution Channel
  - 7.5.4.1 LAMEA Drug Stores and Retail Pharmacies Digestive Health Market by Type
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Type
  - 7.5.5.1.2 Market size and forecast, by Form
  - 7.5.5.1.3 Market size and forecast, by Distribution Channel
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Type
  - 7.5.5.2.2 Market size and forecast, by Form
  - 7.5.5.2.3 Market size and forecast, by Distribution Channel
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Market size and forecast, by Type
  - 7.5.5.3.2 Market size and forecast, by Form
  - 7.5.5.3.3 Market size and forecast, by Distribution Channel
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Type
  - 7.5.5.4.2 Market size and forecast, by Form
  - 7.5.5.4.3 Market size and forecast, by Distribution Channel

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Bayer AG
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 GalaxoSmithKline PLC
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 Pfizer Inc.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 Sanofi
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 Nestle SA
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 Herbalife Nutrition Ltd.
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 BASF SE
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 NOW Health Group Inc.
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Amway Corporation
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 The Bountiful Company (Nature's Bounty)
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments